Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study to Determine the Efficacy of Ferric Carboxymaltose in Preoperative Colorectal Cancer Related Anaemia, and to Develop Biomarkers to Predict Response to This Treatment Strategy

NCT01701310 is registered in ClinicalTrials.gov with Nottingham University Hospitals NHS Trust as lead sponsor.

NCT NCT01701310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01701310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study to Determine the Efficacy of Ferric Carboxymaltose in Preoperative Colorectal Cancer Related Anaemia, and to Develop Biomarkers to Predict Response to This Treatment Strategy
Lead sponsor
Nottingham University Hospitals NHS Trust
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2012
Completion date
December 31, 2014
Enrollment
116 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, colorectal neoplasm